MPR - Medical Professionals Reference

  • Home
  • MPR - Medical Professionals Reference

MPR - Medical Professionals Reference MPR provides daily drug news, medication safety alerts & recalls, and industry-supported drug information & education.

Check out our app for up-to-date drug reference information and clinical tools at your fingertips.

Searching for the latest news and research about COVID-19 and other emerging diseases? Sign up for the Grand Roundup, ou...
01/09/2025

Searching for the latest news and research about COVID-19 and other emerging diseases? Sign up for the Grand Roundup, our curated newsletter to help you stay informed on clinical topics that matter most to you: https://bit.ly/4nramIl

The CDC director is refusing to resign; being confirmed by the Senate means only the president can fire Dr Monarez, a po...
28/08/2025

The CDC director is refusing to resign; being confirmed by the Senate means only the president can fire Dr Monarez, a point made by her lawyer.

In light of this news 4 other senior CDC officials have submitted their resignation.

"Frankly, I’m looking over my shoulder driving home," a Midwestern doctor said, after surrendering a work cellphone to s...
27/08/2025

"Frankly, I’m looking over my shoulder driving home," a Midwestern doctor said, after surrendering a work cellphone to supervisors after their hospital received a subpoena.

"Frankly, I’m looking over my shoulder driving home," a Midwestern doctor said, after surrendering a work cellphone to supervisors after their hospital received a subpoena.

An investigative pill, designed for once daily use, shows significant weight reduction in obesity vs placebo.
26/08/2025

An investigative pill, designed for once daily use, shows significant weight reduction in obesity vs placebo.

The ATTAIN-2 trial evaluated the efficacy and safety of orforglipron in adults with a BMI of greater than or equal to 27kg/m2 and type 2 diabetes.

Searching for the latest news and research about addiction disorders? Sign up for the Grand Roundup, our curated newslet...
25/08/2025

Searching for the latest news and research about addiction disorders? Sign up for the Grand Roundup, our curated newsletter to help you stay informed on clinical topics that matter most to you: https://bit.ly/4klaTsn

Chikungunya vaccine suspended by FDA as Agency say benefit does not outweigh risks.
25/08/2025

Chikungunya vaccine suspended by FDA as Agency say benefit does not outweigh risks.

There have been 4 new reports of serious adverse events related to Ixchiq based on updated Vaccine Adverse Event Reporting System data.

🎧 ICYMI: Two months after the Dept. of HHS fires all 17 members of the Advisory Committee on Immunization Practices, the...
24/08/2025

🎧 ICYMI: Two months after the Dept. of HHS fires all 17 members of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics releases their own, separate immunization schedule. This story and more on the latest MPR Podcast.

The American Academy of Pediatrics releases their own pediatric immunization schedule; The American Heart Association updates guidelines for the

New app-device combo translates glucose fluctuations into personalized recommendations for weight management.
23/08/2025

New app-device combo translates glucose fluctuations into personalized recommendations for weight management.

The Signos Glucose Monitoring System is a mobile device application that receives data from an OTC integrated continuous glucose monitor, the Dexcom Stelo Biosenor.

Sublingual approved to treat fibromyalgia; trial results showed significant reduction in pain intensity scores with the ...
22/08/2025

Sublingual approved to treat fibromyalgia; trial results showed significant reduction in pain intensity scores with the treatment.

The approval was supported by data from 3 double-blind, placebo-controlled trials that included a total of 1474 patients who met the 2016 ACR criteria for diagnosis of fibromyalgia.

New treatment approved to prevent attacks of hereditary angioedema.
22/08/2025

New treatment approved to prevent attacks of hereditary angioedema.

Dawnzera, a prekallikrein-directed antisense oligonucleotide, is supplied as a 80mg/0.8mL solution in a single-dose autoinjector.

📢 New pod out now!🔸 Tensions between exec branch and med associations rachet up as the AAP release their own immunizatio...
21/08/2025

📢 New pod out now!
🔸 Tensions between exec branch and med associations rachet up as the AAP release their own immunization schedule;
🔹 AHA guidelines for blood pressure;
🔸 Wegovy gains approval;
🔹 New fibromyalgia Tx;
🔸 SCD Tx fails to meet endpoint.

The American Academy of Pediatrics releases their own pediatric immunization schedule; The American Heart Association updates guidelines for the

Address


Alerts

Be the first to know and let us send you an email when MPR - Medical Professionals Reference posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to MPR - Medical Professionals Reference:

  • Want your business to be the top-listed Media Company?

Share